Parasites

• Targets parasitic protozoa infections affecting 3.5 billion people globally, including Blastocystis (57% prevalence), Giardia (27%), and Dientamoeba fragilis (12%) in metropolitan areas

• Contains concentrated Artemisia annua extract with proven antimicrobial compounds that disrupt parasitic cell membranes and metabolic processes

• Addresses helminth infections affecting over 25% of the world's population, including 819 million with roundworm and 464 million with whipworm

• 94.4% parasitic clearance rate for Blastocystis infections, matching pharmaceutical effectiveness

• 70% reduction in Giardia parasite load while improving gut structure and immune function

• Significantly faster clearance of Entamoeba histolytica cysts when combined with standard treatment

• Pomegranate peel achieves 97.4% cure rate against Giardia lamblia and complete Blastocystis cyst clearance by day 10

• Myrrh extract reduces Cryptosporidium parasite load while enhancing immune response through IFN-γ activation

• Clinical studies show 82% effectiveness against roundworm and significant reduction in tapeworm egg production

• Achieves 97.4% cure rate against Giardia infections and complete Blastocystis clearance by day 10

• Demonstrates 82% killing rate against roundworm infections and rapid tapeworm paralysis within 90 minutes

• Disrupts parasitic cellular structure by targeting tubulin proteins essential for movement and survival